Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC FHD-609 | 2676211-64-4 | C47H56N8O6 | 100 MG
Supplier: Medchemexpress LLC HY153367100MG
FHD-609 is a PROTAC degrader and inhibitor of Bromodomain-containing protein 9 (BRD9). It targets ncBAF and is used for research on various cancers with mutations in a BAF complex subunit. This compound, when combined with Telomelysin or INO5401, may be useful in adrenocortical carcinoma (ACC) treatment.
- Purity: 98.95%
- Appearance: Solid, white to off-white
- Target: BRD9, epigenetic reader domain, PROTACs
- Demonstrates maintained BRD9 degradation levels and anti-tumor activities in SYO-1 xenograft mouse models
- In vitro solubility: Soluble in DMSO at 100 mg/mL (120.63 mM), requires ultrasonication
- In vivo solubility: Forms clear solutions in 10% DMSO with 90% (20% SBE-β-CD in saline) or 90% corn oil at ≥ 2.5 mg/mL (3.02 mM)
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?